## Publication suite results (100-case dataset)
- **Dataset**: `test_cases_100.json`
- **API**: `http://127.0.0.1:8000`
- **Model**: `evo2_1b`
- **Fast-mode**: True (no evidence calls)

### Summary (positives + negatives)
| Method | Pos Class@1 | 95% CI | Pos Drug@1 | 95% CI | Neg PARP FP | 95% CI |
|---|---:|---:|---:|---:|---:|---:|
| Random | 26.7% | [13.3%, 43.3%] | 13.3% | [3.3%, 26.7%] | 0.0% | [0.0%, 0.0%] |
| Rule (DDRâ†’PARP) | 73.3% | [56.7%, 86.7%] | 70.0% | [53.3%, 86.7%] | 0.0% | [0.0%, 0.0%] |
| Model SP | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |
| Model SPE | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |
| Ablation S | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |
| Ablation P | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |
| Ablation E | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |
| Ablation SP | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |
| Ablation SE | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |
| Ablation PE | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |
| Ablation SPE | 66.7% | [50.0%, 83.3%] | 66.7% | [50.0%, 83.3%] | 0.0% | [0.0%, 0.0%] |

